<DOC>
	<DOCNO>NCT01000571</DOCNO>
	<brief_summary>This study evaluate immunogenicity safety inactivate H1N1 swine-origin monovalent influenza vaccine immunocompromised child young adult .</brief_summary>
	<brief_title>Immunogenicity Safety Inactivated H1N1 Swine-origin Influenza Monovalent Vaccine Immunocompromised Children Young Adults</brief_title>
	<detailed_description>This prospective observational study . This study dictate vaccine administration , vaccine product use . It collect data St Jude patient receive vaccine part clinical care per institutional guideline . Research participant receive two dos inactivated H1N1 swine-origin monovalent influenza vaccine administer 28 day apart part clinical care . Each dose contain 15 mcg hemagglutinin antigen ( HA ) .Follow-up visit schedule 28 day dose day 208+/- 14 day blood work . The day administration first vaccine dose count day 0 . At visit , blood collect assess immunogenicity . Research participant give diary card record symptoms 28 day . They ask bring diary back next visit . Other vaccine-related adverse event also collect retrospective chart review . Children young adult age 6 month 21 year 13 kg great body weight underlying diagnosis cancer , HIV , sickle cell disease receipt stem cell transplant year prior study entry receive inactivate H1N1 swine-origin monovalent influenza vaccine winter/fall 2009-2010 part routine clinical care .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 6 month 21 year age time entry study ; Body weight 13 kg great time entry study ; Participant immunocompromised due cancer , HIV , sickle cell disease receipt stem cell transplant ; Participant participant 's parent/legal guardian available telephone course study ; Written inform consent ( assent , applicable ) obtain ; Potential research participant receive receive H1N1 swineorigin monovalent influenza vaccine within 24 hour study entry . Proven history , RTPCR , H1N1 swineorigin influenza infection prior study entry ; Receipt stem cell transplant within one year prior study entry ; Participation P1088 study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>H1N1 pandemic flu</keyword>
</DOC>